Finally, the prevention of renal fibrosis was secondarily verified by immunoblotting for fibronectin, which was reduced in NR-treated male (significant, P < 0.001) and female (trend, P < 0.10) Alport mice (Supplemental Figure 4). This evidence concerns the gene FN1 and renal fibrosis.